Scotland · NHS Scotland MSAN
Zyban® (bupropion hydrochloride) 150mg prolonged release tablets
MSAN(2020)45 · Level 3 · issued 01 Jun 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Zyban® (bupropion hydrochloride) 150mg prolonged release tablets will be out of stock from | Out of stock | — |
| dependence, are available. | Available | — |
| All Champix® (varenicline tartrate) formulations remain available. Pfizer have advised they | Available | — |
| Various nicotine replacement therapies also remain available. | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2020:45
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
a056804f7e23fe8baca07fe093f6f0d8486032bf0b542ace33ce33e8bb0cfcbcsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2020-45.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.